HJ Möller

2.3k total citations
29 papers, 992 citations indexed

About

HJ Möller is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, HJ Möller has authored 29 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Cognitive Neuroscience. Recurrent topics in HJ Möller's work include Schizophrenia research and treatment (6 papers), Bipolar Disorder and Treatment (5 papers) and Tryptophan and brain disorders (4 papers). HJ Möller is often cited by papers focused on Schizophrenia research and treatment (6 papers), Bipolar Disorder and Treatment (5 papers) and Tryptophan and brain disorders (4 papers). HJ Möller collaborates with scholars based in Germany, United States and United Kingdom. HJ Möller's co-authors include Rainer Rupprecht, Thomas C. Baghai, Cornelius Schüle, B Bondy, Peter Zwanzger, Manfred Ackenheil, Ina Giegling, Dan Rujescu, Peter Zill and Sophia Frangou and has published in prestigious journals such as Neuropsychopharmacology, Molecular Psychiatry and Critical Care.

In The Last Decade

HJ Möller

29 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
HJ Möller Germany 15 357 271 184 165 146 29 992
Rafael Stryjer Israel 19 386 1.1× 156 0.6× 136 0.7× 133 0.8× 148 1.0× 50 1.1k
Masahito Nakataki Japan 19 246 0.7× 242 0.9× 213 1.2× 244 1.5× 230 1.6× 44 924
Johannes M. Hennings Germany 18 274 0.8× 195 0.7× 323 1.8× 131 0.8× 178 1.2× 32 1.1k
Chengge Gao China 22 205 0.6× 225 0.8× 268 1.5× 255 1.5× 260 1.8× 48 1.3k
Li Hui China 19 460 1.3× 203 0.7× 322 1.8× 300 1.8× 131 0.9× 86 1.2k
Roland Ricken Germany 18 350 1.0× 143 0.5× 133 0.7× 208 1.3× 82 0.6× 35 983
Wolfgang Maier Germany 14 204 0.6× 167 0.6× 120 0.7× 107 0.6× 162 1.1× 17 828
Ertuğrul Eşel Türkiye 17 278 0.8× 113 0.4× 99 0.5× 131 0.8× 103 0.7× 62 951
Jolanta Kucharska–Mazur Poland 19 264 0.7× 207 0.8× 269 1.5× 113 0.7× 258 1.8× 70 987
Virginia Soria Spain 21 345 1.0× 203 0.7× 246 1.3× 293 1.8× 258 1.8× 67 1.4k

Countries citing papers authored by HJ Möller

Since Specialization
Citations

This map shows the geographic impact of HJ Möller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HJ Möller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HJ Möller more than expected).

Fields of papers citing papers by HJ Möller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HJ Möller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HJ Möller. The network helps show where HJ Möller may publish in the future.

Co-authorship network of co-authors of HJ Möller

This figure shows the co-authorship network connecting the top 25 collaborators of HJ Möller. A scholar is included among the top collaborators of HJ Möller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HJ Möller. HJ Möller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meindl, Thomas, Walter Koch, Arun L.W. Bokde, et al.. (2011). Strukturelle und funktionelle neuronale Konnektivität bei der Alzheimer-Krankheit. Der Nervenarzt. 83(7). 878–887. 26 indexed citations
2.
Frodl, Thomas, Nikolaos Koutsouleris, Ronald Bottlender, et al.. (2008). Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression. Molecular Psychiatry. 13(12). 1093–1101. 120 indexed citations
3.
Jäger, M., Thomas Messer, Gerd Laux, et al.. (2008). Standardized Remission Criteria in Schizophrenia: Descriptive Validity and Comparability with Previously Used Outcome Measures. Pharmacopsychiatry. 41(5). 190–195. 14 indexed citations
4.
Severus, W. Emanuel, Nikolaus Kleindienst, Florian Seemüller, et al.. (2008). What is the optimal serum lithium level in the long‐term treatment of bipolar disorder – a review?. Bipolar Disorders. 10(2). 231–237. 92 indexed citations
6.
Dresel, S., Thomas Frodl, Christian la Fougère, et al.. (2007). Dual-isotope SPECT imaging of striatal dopamine: A comparative study between never treated and haloperidol treated first episode schizophrenic patients. Pharmacopsychiatry. 40(5). 2 indexed citations
7.
Bender, Wolfram, Margot Albus, HJ Möller, & Felix Tretter. (2006). Towards Systemic Theories in Biological Psychiatry. Pharmacopsychiatry. 39. 4–9. 17 indexed citations
8.
Ruhrmann, Stephan, Frauke Schultze‐Lutter, Michael Wagner, et al.. (2006). 0184 INTERVENTION IN THE LATE INITIAL PRODROMAL STATE (LIPS)OF PSYCHOSIS. Schizophrenia Research. 86. S96–S96. 2 indexed citations
9.
Meisenzahl, Eva, S Krejcová, Ina Giegling, et al.. (2006). Plexin B3 is genetically associated with verbal performance and white matter volume in human brain. Molecular Psychiatry. 12(2). 190–194. 34 indexed citations
10.
Adli, Mazda, Katja Wiethoff, Katja Wiethoff, et al.. (2005). Evaluating algorithm-guided treatment for depression: The German Algorithm Project (GAP). Pharmacopsychiatry. 38(5). 2 indexed citations
11.
Spellmann, Ilja, Michael Riedel, Norbert Müller, et al.. (2005). Cognitive benefits of quetiapine versus risperidone in schizophrenia. Pharmacopsychiatry. 38(5). 2 indexed citations
12.
Schwarz, Markus, Holger Krönig, Michael Riedel, et al.. (2005). IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 256(2). 72–76. 63 indexed citations
13.
Baghai, Thomas C., Peter Zwanzger, Cornelius Schüle, et al.. (2004). SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Molecular Psychiatry. 9(11). 1030–1036. 258 indexed citations
14.
Stübner, Susanne, R. Grohmann, Gabriela Peretti Wagner, et al.. (2004). Severe and Uncommon Involuntary Movement Disorders due to Psychotropic Drugs. Pharmacopsychiatry. 37. 54–64. 69 indexed citations
15.
Adli, Mazda, A. John Rush, HJ Möller, & Michael Bauer. (2003). Algorithms for Optimizing the Treatment of Depression: Making the Right Decision at the Right Time. Pharmacopsychiatry. 36. 222–229. 38 indexed citations
16.
Rujescu, Dan, et al.. (2003). M129V variation in the prion protein may influence cognitive performance. Molecular Psychiatry. 8(11). 937–941. 34 indexed citations
17.
Rujescu, Dan, Ina Giegling, B Bondy, et al.. (2002). Association of anger-related traits with SNPs in the TPH gene. Molecular Psychiatry. 7(9). 1023–1029. 79 indexed citations
18.
Zwanzger, Peter, Daniela Eser, Sue A. Aicher, et al.. (2002). Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic–Pituitary–Adrenal-Axis Activity: A Placebo-Controlled Study. Neuropsychopharmacology. 28(5). 979–984. 64 indexed citations
19.
Kasper, Siegfried, et al.. (1994). Use of light therapy in German psychiatric hospitals. European Psychiatry. 9(6). 288–292. 8 indexed citations
20.
Saletu, Bernd, et al.. (1990). Propentofylline in Adult-Onset Cognitive Disorders: Double-Blind, Placebo-Controlled, Clinical, Psychometric and Brain Mapping Studies. Neuropsychobiology. 24(4). 173–184. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026